Sean F. Scanlan Treace Medical Concepts, Inc. (TMCI) insider trading activity

Sean F. Scanlan is Chief Innovation Officer of TREACE MEDICAL CONCEPTS, INC.. Currently has a direct ownership of 250,074 shares of TMCI, which is worth approximately $1.36 Million. The most recent transaction as insider was on Sep 12, 2024, when has been sold 33,750 shares (Common Stock) at a price of $0.1 per share, resulting in proceeds of $3,375. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 250K

162.07% 3M change

677.01% 12M change

Total Value Held $1.36 Million

Sean F. Scanlan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 12 2024	BUY Exercise of conversion of derivative security	$3,375 $0.1 p/Share	33,750 Added 11.89%	250,074 Common Stock
Aug 09 2024	BUY Grant, award, or other acquisition	-	120,900 Added 35.85%	216,324 Common Stock
Mar 10 2024	SELL Payment of exercise price or tax liability	-	1,396 Reduced 1.44%	95,424 Common Stock
Mar 08 2024	SELL Payment of exercise price or tax liability	-	389 Reduced 0.4%	96,820 Common Stock
Jan 10 2024	BUY Grant, award, or other acquisition	-	65,025 Added 40.08%	97,209 Common Stock
Nov 02 2023	SELL Payment of exercise price or tax liability	-	211 Reduced 0.65%	32,184 Common Stock
May 16 2023	SELL Open market or private sale	$636,000 $25.44 p/Share	25,000 Reduced 43.56%	32,395 Common Stock
May 16 2023	BUY Exercise of conversion of derivative security	$2,500 $0.1 p/Share	25,000 Added 30.34%	57,395 Common Stock
Mar 10 2023	BUY Grant, award, or other acquisition	-	22,925 Added 41.44%	32,395 Common Stock
Mar 09 2023	SELL Open market or private sale	$12,327 $24.41 p/Share	505 Reduced 5.06%	9,470 Common Stock
Feb 15 2023	SELL Open market or private sale	$542,250 $21.69 p/Share	25,000 Reduced 71.48%	9,975 Common Stock
Feb 15 2023	BUY Exercise of conversion of derivative security	$2,500 $0.1 p/Share	25,000 Added 41.68%	34,975 Common Stock
Jan 12 2023	SELL Open market or private sale	$639,250 $25.57 p/Share	25,000 Reduced 71.48%	9,975 Common Stock
Jan 12 2023	BUY Exercise of conversion of derivative security	$2,500 $0.1 p/Share	25,000 Added 41.68%	34,975 Common Stock
Nov 14 2022	SELL Open market or private sale	$606,750 $24.27 p/Share	25,000 Reduced 71.48%	9,975 Common Stock
Nov 14 2022	BUY Exercise of conversion of derivative security	$2,500 $0.1 p/Share	25,000 Added 41.68%	34,975 Common Stock
Oct 24 2022	BUY Grant, award, or other acquisition	-	3,400 Added 25.42%	9,975 Common Stock
Mar 08 2022	BUY Grant, award, or other acquisition	-	6,575 Added 50.0%	6,575 Common Stock
Mar 02 2022	SELL Open market or private sale	$520,500 $20.82 p/Share	25,000 Reduced 100.0%	0 Common Stock
Mar 02 2022	BUY Exercise of conversion of derivative security	$26,250 $1.05 p/Share	25,000 Added 50.0%	25,000 Common Stock
Feb 09 2022	SELL Open market or private sale	$78,080 $20.16 p/Share	3,873 Reduced 100.0%	0 Common Stock
Feb 09 2022	BUY Exercise of conversion of derivative security	$4,067 $1.05 p/Share	3,873 Added 50.0%	3,873 Common Stock
Feb 08 2022	SELL Open market or private sale	$422,963 $20.02 p/Share	21,127 Reduced 100.0%	0 Common Stock
Feb 08 2022	BUY Exercise of conversion of derivative security	$22,183 $1.05 p/Share	21,127 Added 50.0%	21,127 Common Stock
Jan 11 2022	SELL Open market or private sale	$177,821 $20.12 p/Share	8,838 Reduced 100.0%	0 Common Stock

SFS

Sean F. Scanlan

Chief Innovation Officer

Ponte Vedra, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TMCI shares.

Notify only if

Value

Insider Trading

Get notified when an Treace Medical Concepts, Inc. insider buys or sells TMCI shares.

Notify only if

Operation

Value

Type

News

Receive news related to TREACE MEDICAL CONCEPTS, INC.

Track Activities on TMCI

Account